ACTIVE

B.K. PHARMA (SRL)

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

26,6 k €

-54.4% YoY

Gross margin

112,7 k €

-25.5% YoY

Equity

192,6 k €

+16.0% YoY

What does B.K. PHARMA do?

B.K. PHARMA is a Private limited company incorporated in 2011. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Anderlecht.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0834.173.472

Incorporation

01/03/2011

Legal form

Private limited company

Registered office

Rue Wayez 48
1070 Anderlecht · BruxellesSee on map

Contributed capital

6 500,00 €

Latest accounts

31/12/2025

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores

Signals

ProfitableSolid equityLow riskPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 15 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011
Income statement
Gross margin	112,7 k €	-25.5%	151,2 k €	+19.3%	126,8 k €	+1.0%	125,5 k €	+0.3%	125,1 k €	+2.8%	121,7 k €	+11.2%	109,4 k €	-29.9%	156,2 k €	-24.4%	206,6 k €	+2.1%	202,3 k €	+81.2%	111,6 k €	-4.4%	116,7 k €	+109%	55,9 k €	-27.8%	77,4 k €	+78.7%	43,3 k €
EBITDA	60,7 k €	-40.1%	101,3 k €	+43.7%	70,5 k €	+17.0%	60,3 k €	+3.5%	58,2 k €	-41.4%	99,3 k €	+23.9%	80,2 k €	-30.6%	115,5 k €	-29.3%	163,4 k €	+5.7%	154,6 k €	+58.0%	97,9 k €	-13.7%	113,4 k €	+107%	54,7 k €	-19.9%	68,2 k €	+109%	32,7 k €
Operating result	37,7 k €	-53.6%	81,3 k €	+67.1%	48,6 k €	+61.7%	30,1 k €	-4.4%	31,5 k €	-36.4%	49,5 k €	+142%	20,4 k €	-63.4%	55,8 k €	-47.2%	105,7 k €	+8.5%	97,4 k €	+196%	32,9 k €	-33.2%	49,3 k €	+391%	-16,9 k €	-273%	9,8 k €	+128%	-35 k €
Net result	26,6 k €	-54.4%	58,3 k €	+78.0%	32,8 k €	+56.1%	21 k €	+2.4%	20,5 k €	-22.2%	26,3 k €	+1241%	2 k €	-93.1%	28,5 k €	-58.8%	69,3 k €	+4.5%	66,3 k €	+962%	6,2 k €	-71.7%	22 k €	+144%	-49,8 k €	-197%	-16,7 k €	+67.5%	-51,5 k €
Balance sheet
Equity	192,6 k €	+16.0%	166 k €	+52.4%	108,9 k €	+38.5%	78,6 k €	+36.4%	57,6 k €	+55.2%	37,1 k €	+0.9%	36,8 k €	+5.6%	34,8 k €	+114%	16,3 k €	+196%	-17 k €	+79.6%	-83,3 k €	+7.0%	-89,5 k €	+19.7%	-111,6 k €	-80.6%	-61,8 k €	-37.2%	-45 k €
Total assets	421,5 k €	-6.5%	451 k €	+0.9%	447 k €	-2.8%	459,9 k €	-10.8%	515,7 k €	-1.3%	522,4 k €	-2.0%	533,1 k €	-8.9%	585,1 k €	-10.8%	656 k €	+5.7%	620,8 k €	-1.5%	630,2 k €	-8.4%	687,7 k €	-6.3%	733,8 k €	+2.2%	717,7 k €	+50.5%	476,9 k €
Cash	78 k €	-36.7%	123,3 k €	+6.9%	115,4 k €	+44.0%	80,1 k €	-39.2%	131,8 k €	-15.9%	156,6 k €	+17.9%	132,8 k €	-5.2%	140 k €	-11.9%	159 k €	+150%	63,7 k €	-1.6%	64,8 k €	+4.4%	62 k €	-5.3%	65,5 k €	+29.4%	50,6 k €	-15.9%	60,2 k €
Debts	228,9 k €	-19.7%	285 k €	-15.7%	338,2 k €	-11.3%	381,3 k €	-16.8%	458,1 k €	-5.6%	485,2 k €	-2.2%	496,3 k €	-9.8%	550,3 k €	-14.0%	639,8 k €	+0.3%	637,8 k €	-10.6%	713,5 k €	-8.1%	776,4 k €	-8.1%	844,5 k €	+8.5%	778,6 k €	+49.2%	521,9 k €
Other
Workforce	–		–		–		1,0 ETP	0.0%	1,0 ETP		–		–		0,7 ETP		–		–		–		–		–		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 2 ended

Active mandates

NABIL MACKI

Mandate

Active

YOUSSEF BEN HAMMOU

Mandate

Active

Ended mandates

HASSAN KHAZRI

Manager

Ended

SALIM BRAHIM

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
POLYPHARMA● Active	0809.382.450

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	28/08/2026	23/07/2025	30/08/2024	28/07/2023	30/09/2022	16/08/2021
General meeting	31/07/2026	30/05/2025	30/06/2024	30/06/2023	30/06/2022	30/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

15 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	31/07/2026	28/08/2026	French	PDF
Micro model	31/12/2024	30/05/2025	23/07/2025	French	PDF
Micro model	31/12/2023	30/06/2024	30/08/2024	French	PDF
Abridged model	31/12/2022	30/06/2023	28/07/2023	French	PDF
Abridged model	31/12/2021	30/06/2022	30/09/2022	French	PDF
Abridged model	31/12/2020	30/06/2021	16/08/2021	French	PDF
Abridged model	31/12/2019	30/06/2020	21/08/2020	French	PDF
Abridged model	31/12/2018	01/07/2019	23/08/2019	French	PDF
Abridged model	31/12/2017	30/06/2018	27/07/2018	French	PDF
Abridged model	31/12/2016	30/06/2017	17/07/2017	French	PDF
Abridged model	31/12/2015	30/06/2016	17/08/2016	French	PDF
Abridged model	31/12/2014	30/06/2015	31/08/2015	French	PDF
Abridged model	31/12/2013	30/06/2014	29/08/2014	French	PDF
Abridged model	31/12/2012	01/07/2013	30/08/2013	French	PDF
Abridged model	31/12/2011	30/06/2012	30/08/2012	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 2 ended

Active mandates

NABIL MACKI

Mandate

Active

YOUSSEF BEN HAMMOU

Mandate

Active

Ended mandates

HASSAN KHAZRI

Manager

Ended

SALIM BRAHIM

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates21/11/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
PDF
Mandates29/06/2023
DEMISSIONS, NOMINATIONS
PDF
Mandates24/09/2020
DEMISSIONS, NOMINATIONS - MODIFICATION FORME JURIDIQUE
PDF
Mandates20/08/2020
DEMISSIONS, NOMINATIONS
PDF
Mandates04/10/2018
DEMISSIONS, NOMINATIONS
PDF
Mandates27/10/2015
DEMISSIONS, NOMINATIONS
PDF
Mandates14/07/2015
DEMISSIONS, NOMINATIONS
PDF
Mandates22/04/2015
DEMISSIONS, NOMINATIONS
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202526,6 k €↓
2024
Annual accounts 202458,3 k €↑
2023
Annual accounts 202332,8 k €↑
2022
Annual accounts 202221 k €↑
2021
Annual accounts 202120,5 k €↓
2021
Name changeBK PHARMA
2020
Annual accounts 202026,3 k €↑
2019
Annual accounts 20192 k €↓
2018
Annual accounts 201828,5 k €↓
2017
Annual accounts 201769,3 k €↑
2016
Annual accounts 201666,3 k €↑
2015
Annual accounts 20156,2 k €↓
2014
Annual accounts 201422 k €↑
2013
Annual accounts 2013-49,8 k €↓
2012
Annual accounts 2012-16,7 k €↑
2011
Annual accounts 2011-51,5 k €
01/03/2011
IncorporationPrivate limited company
2011
Name changeB.K. PHARMA

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

B.K. PHARMA (SRL)

Overview

What does B.K. PHARMA do?

Trend over 15 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline